ABSTRACT
No disponible
Subject(s)
Humans , Male , Female , Smoking/epidemiology , Smoking/prevention & control , Nicotiana/adverse effects , Tobacco Industry/legislation & jurisprudence , Tobacco-Derived Products Commerce , Smoking/legislation & jurisprudence , Health Surveillance/legislation & jurisprudence , Health Surveillance/standardsABSTRACT
No disponible
Subject(s)
Humans , Male , Female , Tobacco Smoke Pollution/prevention & control , Smoking/prevention & control , Smoking Prevention , Smoking Prevention , Epidemiological Monitoring/trends , Spain/epidemiology , Costs and Cost Analysis/trends , 50303 , Primary Prevention , Epidemiological MonitoringABSTRACT
No disponible
Subject(s)
Humans , Male , Female , Referral and Consultation , Tobacco Smoke Pollution/prevention & control , Smoking/prevention & control , Smoking Prevention , Spain/epidemiology , Public Health/methods , Patient Selection , Computer Communication Networks/trendsABSTRACT
No disponible
Subject(s)
Humans , Tobacco Use Disorder/therapy , Bupropion/pharmacokinetics , Cytochrome P-450 Enzyme System/analysis , Nortriptyline/pharmacokinetics , Clonidine/pharmacokinetics , Vaccines/therapeutic use , Receptors, Nicotinic/analysisABSTRACT
No disponible
Subject(s)
Humans , Tobacco Use Disorder/therapy , Tobacco Use Cessation/methods , Behavior, Addictive/therapy , Clinical Protocols , Recurrence/prevention & controlSubject(s)
Community Medicine , Family Practice , Smoking Prevention , Societies, Medical , Humans , SpainABSTRACT
No disponible
Subject(s)
Humans , Tobacco Use Disorder/therapy , Social Support , Tobacco Use Cessation/methods , Tobacco Use Disorder/psychologyABSTRACT
No disponible
No disponible
Subject(s)
Humans , Physicians, Family/trends , Tobacco Use Disorder/prevention & control , Health Promotion/trends , Primary Health Care/methodsABSTRACT
Due to the recurrent chronic nature of tobacco dependence, health care professionals should know the most common reasons for relapses and offer smokers who have stopped smoking a preventive treatment. In our setting, some authors state that the main causes for which smokers relapse are the negative emotional states and social pressures. Among the prevention strategies of relapse are providing the patient information, reinforcing his/her decision to stop smoking and helping the patient identify and face the danger situations for the maintenance of abstinence.
Subject(s)
Smoking Cessation , Smoking Prevention , Tobacco Use Disorder/prevention & control , Humans , Smoking Cessation/methodsABSTRACT
A causa de la naturaleza crónica recidivante de la dependencia al tabaco, los profesionales sanitarios deberían conocer los motivos más comunes de recaídas y ofrecer a los fumadores que han abandonado el tabaco un tratamiento preventivo de éstas. En nuestro medio algunos autores afirman que las causas principales por las que los fumadores recaen son los estados emocionales negativos y las presiones sociales. Entre las estrategias de prevención de las recaídas se incluyen proporcionar información al paciente, reforzar su decisión de abandonar el tabaco y ayudarle a identificar y afrontar las situaciones de peligro para el mantenimiento de la abstinencia
Due to the recurrent chronic nature of tobacco dependence, health care professionals should know the most common reasons for relapses and offer smokers who have stopped smoking a preventive treatment. In our setting, some authors state that the main causes for which smokers relapse are the negative emotional states and social pressures. Among the prevention strategies of relapse are providing the patient information, reinforcing his/her decision to stop smoking and helping the patient identify and face the danger situations for the maintenance of abstinence
Subject(s)
Humans , Tobacco Use Disorder/prevention & control , Tobacco Use Cessation/methods , Tobacco Use Disorder/prevention & controlSubject(s)
Nicotine/therapeutic use , Smoking Cessation , Tobacco Use Disorder/drug therapy , Antidepressive Agents, Second-Generation/therapeutic use , Benzazepines/therapeutic use , Bupropion/administration & dosage , Bupropion/therapeutic use , Cannabinoid Receptor Antagonists , Humans , Nicotine/administration & dosage , Nicotine/analogs & derivatives , Piperidines/therapeutic use , Pyrazoles/therapeutic use , Quinoxalines/therapeutic use , Receptors, Nicotinic/drug effects , Rimonabant , Smoking Cessation/methods , Smoking Cessation/psychology , Time Factors , Tobacco Use Disorder/psychology , VareniclineABSTRACT
No disponible
Subject(s)
Humans , Tobacco Use Cessation/methods , Tobacco Use Cessation/psychology , Tobacco Use Disorder/drug therapy , Tobacco Use Disorder/psychology , Antidepressive Agents, Second-Generation/therapeutic use , Benzazepines/therapeutic use , Bupropion , Nicotine , Piperidines/therapeutic use , Pyrazoles/therapeutic use , Quinoxalines/therapeutic use , Receptors, Cannabinoid/antagonists & inhibitors , Receptors, Nicotinic , Time FactorsABSTRACT
No disponible
No disponible
Subject(s)
Humans , Tobacco Use Disorder/legislation & jurisprudence , Tobacco Use Cessation/legislation & jurisprudence , Tobacco Use Disorder/prevention & control , European Union , Health Policy/legislation & jurisprudenceABSTRACT
No disponible
Subject(s)
Humans , Tobacco Use Disorder , Tobacco Use Cessation , Nicotine , Counseling , Habituation, PsychophysiologicABSTRACT
No disponible
